Kevin Hu

4PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 18, 2023
RPL22 is a tumor suppressor in MSI-high cancers and a key splicing regulator of MDM4.

Hannah N W Weinstein, Kevin Hu, Lisa Fish

|Apr 12, 2020
Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.

Josh Lewis Stern, Grace Hibshman, Kevin Hu

Pageof 1